Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Generic Lenalidomide: An opportunity to address the balance of administrative burden and drug safety

Published:2022-06-10 Issue:3 Volume:109 Page:305-306
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:European J of Haematology

Author:

Patrick Hannah¹^ORCID,Ramasamy Karthik²^ORCID,Rashid Sabia¹

Affiliation:

1. Lewisham and Greenwich NHS Trust London UK

2. Hematology Department Oxford University Hospitals Oxford UK

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13808

Reference9 articles.

1. Teratogen update: Clinical aspects of thalidomide embryopathy—A continuing preoccupation

2. Accessed March 2022.https://www.ema.europa.eu/en/medicines/human/EPAR/revlimid

3. Accessed March 2022.imnovid‐epar‐risk‐management‐plan‐summary_en.pdf (europa.eu)

4. Thalidomide is distributed into human semen after oral dosing;Teo SK;Drug Metabo Dispos,2001

5. Guideline on good pharmacovigilance practices (GVP) ‐ Module XVI – Risk minimisation measures: selection of tools and effectiveness indicators (Rev 2). Accessed March 2022.europa.eu

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP